Federal contract award
HHSO100200900116C
ANTIVIRAL DRUGS ( FOR THE HHS CRITICAL WORKFORCE (TREATMENT COURSES) FROM ROCHE
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Health and Human Services |
| Office | BARDA - ASPR / DAAPPO / BARDA DCMA |
| NAICS | 325412 — Pharmaceutical Preparation Manufacturing |
| PSC | 6505 — Drugs and Biologicals |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $9.4M |
| Current contract value | $9.4M |
| Potential contract value / ceiling | $19.0M |
| Start date | Sep 30, 2009 |
| Current end date | Sep 29, 2010 |
| Potential end date | Sep 29, 2010 |
| Latest award activity | Jan 9, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 1 of 1 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Jan 9, 2025 | P00002 | $-3.5K | ANTIVIRAL DRUGS ( FOR THE HHS CRITICAL WORKFORCE (TREATMENT COURSES) FROM ROCHE |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.